Outcomes of Robotic Lung Resection After Neoadjuvant Therapy, 2018-2024

A retrospective review of 150 patients who underwent robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer. The dataset, authored by Camille Yongue and uploaded to figshare, covers surgeries performed from January 2018 to October 2024. It includes patient demographics, treatment details, operative metrics, complications, and survival outcomes.

Use Cases

• Analyze conversion rates and major morbidity based on the reported <1% conversion and 21 patients with grade III complications.
• Model survival outcomes based on the reported median postoperative survival of 513 days and 90-day mortality figures.
• Study the relationship between time from therapy to surgery and operative outcomes based on the reported median 6-week interval.
• Compare complication profiles based on the reported prevalence of atrial fibrillation and effusion as primary grade III events.

Strengths

• Includes 150 patient records from a consecutive series, providing a defined cohort size.
• Reports specific clinical metrics, including a median operative time of 152 minutes and median blood loss of 20 mL.
• Contains detailed treatment history, with 92% receiving chemotherapy and 65% receiving immunotherapy preoperatively.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown for the underlying data table, which may limit suitability assessment.
• Data may reflect temporal and institutional bias inherent to the two-surgeon, single-institution study design.

Provenance

Source

figshare

Collection Method

Retrospective review of a consecutive series of patients from two surgeons.

Time Range

January 2018 to October 2024

Freshness

Last updated 2026-05-20 13:54:26; freshness should be verified.